Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial.

Saved in:
Bibliographic Details
Title: Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial.
Authors: Woodhouse LJ; Stroke Trials Unit, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK., Appleton JP; Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK., Ankolekar S; Department of Neurology, King's College Hospital NHS Trust, London, UK., England TJ; Vascular Medicine, Division of Medical Sciences and GEM, Royal Derby Hospital, Derby, UK., Mair G; UK Dementia Research Institute, The University of Edinburgh Centre for Clinical Brain Sciences, Edinburgh, UK., Muir K; Neurology, University of Glasgow, Glasgow, UK., Price CI; Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK., Pocock S; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK., Randall M; Department of Neurology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Robinson TG; Department of Cardiovascular Sciences, and NIHR Biomedical Research Unit for Cardiovascular Diseases, University of Leicester, Leicester, UK., Roffe C; Institute for Science and Technology in Medicine, Keele University, Keele, UK., Sandset EC; Department of Neurology, Oslo University Hospital, Oslo, Norway.; Research and Development, Norwegian Air Ambulance Foundation, Oslo, Norway., Saver JL; Department of Neurology and Comprehensive Stroke Center, David Geffen School of Medicine, Los Angeles, California, USA., Siriwardena AN; Community and Health Research Unit, University of Lincoln, Lincoln, UK., Sprigg N; Stroke Trials Unit, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK.; Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK., Wardlaw JM; UK Dementia Research Institute, The University of Edinburgh Centre for Clinical Brain Sciences, Edinburgh, UK., Bath PM; Stroke Trials Unit, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK.; Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Corporate Authors: RIGHT-2 Investigators
Source: BMJ neurology open [BMJ Neurol Open] 2023 Jun 27; Vol. 5 (1), pp. e000424. Date of Electronic Publication: 2023 Jun 27 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: British Medical Association Country of Publication: England NLM ID: 101775450 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-6140 (Electronic) Linking ISSN: 26326140 NLM ISO Abbreviation: BMJ Neurol Open Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2632-6140
DOI:10.1136/bmjno-2023-000424